enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Omalizumab - Wikipedia

   en.wikipedia.org/wiki/Omalizumab

   Omalizumab, sold under the brand name Xolair among others, is an injectable medication to treat severe persistent allergic forms of asthma, nasal polyps, urticaria (hives), [10] [11] and immunoglobulin E-mediated food allergy. [12]

3. Children with multiple food allergies may get relief with new ...

   www.aol.com/news/children-multiple-food...

   A drug already approved for asthma and chronic hives may protect ... Lighter Side. Medicare. ... 165 children and adolescents who received injections of the drug Xolair were able to consume higher ...

4. Newly approved drug protects against multiple food allergies ...

   www.aol.com/news/newly-approved-drug-protects...

   The injectable drug was approved in 2003 under the name Xolair for chronic hives and allergic asthma, but now there was evidence it could also protect against severe allergic reactions to food ...

5. FDA approves medication used to treat asthma for use in ... - AOL

   www.aol.com/news/fda-approves-medication-used...

   The US Food and Drug Administration on Friday approved a medication called Xolair to help lessen the severity of an accidental allergic reaction in people who are allergic to multiple foods.

6. Autoimmune urticaria - Wikipedia

   en.wikipedia.org/wiki/Autoimmune_urticaria

   However, they can have significant side effects, especially when used long-term, and are usually used for short periods. Biologics, such as omalizumab , which is an anti-IgE antibody , can be used in cases of chronic autoimmune urticaria that do not respond to other treatments. [ 32 ]

7. Immunoglobulin E - Wikipedia

   en.wikipedia.org/wiki/Immunoglobulin_E

   Xolair has been approved in many countries for treating severe, persistent allergic asthma. It has also been approved in March 2014 in the European Union [36] and the U. S. [37] for treating chronic spontaneous urticaria, which cannot be adequately treated with H1-antihistamines. In the second approach, antibodies specific for a domain of 52 ...

8. FDA Files Genentech's Supplemental Biologics License ...

   www.aol.com/news/2013-10-11-fda-files-genentechs...

   FDA Files Genentech's Supplemental Biologics License Application of Xolair ® (omalizumab) for Chronic Idiopathic Urticaria (CIU) CIU is a skin condition characterized by red, swollen, itchy hives ...

9. Drug-induced urticaria - Wikipedia

   en.wikipedia.org/wiki/Drug-induced_urticaria

   One of the most prevalent forms of adverse drug reactions is cutaneous reactions, [1] with drug-induced urticaria ranking as the second most common type, preceded by drug-induced exanthems. [2] Urticaria, commonly known as hives , manifests as weals, itching, burning, redness, swelling, and angioedema —a rapid swelling of lower skin layers ...